UC Brain Tumor Center

234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)

All Clinical Studies

AddToAny

Share this
Topic Study No. Clinical Trial Protocol Investigators
Acoustic Neuroma Investigator Initiated A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Backup Stereotactic Radiation Therapy Theodosopoulos (PI)
Jr.
All Tumors (Newly Diagnosed) OBTS Ohio Brain Tumor Study (OBTS) McPherson (PI)
Brain Metastases RTOG 0933 A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases Redmond (PI)
Breneman
Glioblastoma UCC-R2 Elderly GBM A phase II window study of front-line Axitinib followed by Axitinib and radiation for Elderly patients with Glioblastoma Multiforme (GBM) Chaudhary (PI)
Glioblastoma RTOG 0837 Randomized, Phase Il, Double-Blind, Placebo-Controlled Trial Of Conventional Chemoradiation And Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation And Adjuvant Temozolomide Plus Placebo In Patients With Newly Diagnosed Glioblastoma Redmond (PI)
Glioblastoma 020221 A Phase II Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme (GBM). Chaudhary (PI)
Glioblastoma CDX110-04 An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma Chaudhary (PI)
Glioblastoma NCCTG N0877 Phase I/Randomized Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme Chaudhary (PI)
Glioblastoma 20090505 A Phase 1 First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 595 in Subjects With Recurrent Malignant Glioma Expressing Mutant Epidermal Growth Factor Receptor Variant III (EGFRvIII) (PI)
Chaudhary
Glioblastoma CDX110-06 A Phase II Study of Rindopepimut/GM-CSF in Patients with Relapsed EGFRvIII-Positive Glioblastoma Chaudhary (PI)